Skip to main content

Medical Subject Headings

Search from vocabulary

Content language

Concept information

... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Immunoproteins > Immunoglobulins > Immunoglobulin Constant Regions > Immunoglobulin Fc Fragments > Etanercept
... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Serum Globulins > Immunoglobulins > Immunoglobulin Constant Regions > Immunoglobulin Fc Fragments > Etanercept
... > Amino Acids, Peptides, and Proteins > Proteins > Globulins > Serum Globulins > Immunoglobulins > Immunoglobulin Constant Regions > Immunoglobulin Fc Fragments > Etanercept
... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Immunoproteins > Immunoglobulins > Immunoglobulin Fragments > Immunoglobulin Fc Fragments > Etanercept
... > Amino Acids, Peptides, and Proteins > Proteins > Blood Proteins > Serum Globulins > Immunoglobulins > Immunoglobulin Fragments > Immunoglobulin Fc Fragments > Etanercept
... > Amino Acids, Peptides, and Proteins > Proteins > Globulins > Serum Globulins > Immunoglobulins > Immunoglobulin Fragments > Immunoglobulin Fc Fragments > Etanercept
... > Amino Acids, Peptides, and Proteins > Peptides > Peptide Fragments > Immunoglobulin Fragments > Immunoglobulin Fc Fragments > Etanercept
... > Amino Acids, Peptides, and Proteins > Proteins > Membrane Proteins > Receptors, Cell Surface > Receptors, Immunologic > Receptors, Cytokine > Receptors, Tumor Necrosis Factor > Etanercept

Preferred term

Etanercept  

Type

  • Topical Descriptor

Broader concept

Entry terms

  • Enbrel
  • Erelzi
  • Etanercept-szzs
  • Fusion Protein, TNFR-Fc
  • Recombinant Human Dimeric TNF Receptor Type II IgG Fusion Protein
  • Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein
  • TNF Receptor Type II IgG Fusion Protein
  • TNF Receptor Type II-IgG Fusion Protein
  • TNFR Fc Fusion Protein
  • TNFR-Fc Fusion Protein

Scope note

  • A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.

History note

  • 2016 (1997)

In other languages

URI

http://www.yso.fi/onto/mesh/D000068800

Download this concept:

RDF/XML TURTLE JSON-LD Created 7/9/15, last modified 12/14/17